Skip to main content
. 2018 May 15;33(9):859–871. doi: 10.1007/s10654-018-0407-7

Table 3.

Serum phosphate levels and all-cause mortality in RS-I and RS-II, adjusted for age, BMI and smoking, follow-up until year 2012

Men Women
no events HR* (95% CI) p no events HR* (95% CI) p
RS-I 810/1577 1.58 (1.34–1.87) < 0.001 821/2154 0.85 (0.71–1.00) 0.056
RS-II 262/1133 1.14 (0.85–1.53) 0.378 207/1361 1.14 (0.81–1.60) 0.439
Studies combined 1072/2710 1.46 (1.26–1.69) < 0.001 1028/3515 0.90 (0.77–1.05) 0.176

Statistically significant p-values (<0.05) are highlighted in bold font

*Hazard ratios from Weibull models, expressed per 1 mg/dL (0.32 mmol/L) increase in phosphate levels

Studies combined from meta-analyses using fixed-effect models